Morgan Stanley Ponders How Potential Danone Acquisition Could Affect Hospira

By: via Benzinga
In a report published Monday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Hospira (NYSE: HSP). In the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.